Hart & Hart LLC Opines on At-the-Market Stock Offering
Sunshine Biopharma has received legal counsel confirmation that its proposed $4 million At-the-Market issuance of common stock is validly authorized and issuable under applicable securities laws.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day